Cargando…

Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness Assessment

Purpose: The Treatment Effectiveness Assessment (TEA) is a patient-centered instrument for evaluating treatment progress and recovery from substance use disorders, including opioid use disorder (OUD). We assessed the TEA’s reliability and validity and determined minimal clinically important differen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, Walter, Nadipelli, Vijay R, Solem, Caitlyn T, Farabee, David, Ronquest, Naoko A, Perrochet, Brian, Learned, Susan M, Deshpande, Chinmay G, Heidbreder, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556477/ https://www.ncbi.nlm.nih.gov/pubmed/31239805 http://dx.doi.org/10.2147/SAR.S198361

Ejemplares similares

Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study
por: Ling, Walter, et al.
Publicado: (2020)

Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study
por: Ling, Walter, et al.
Publicado: (2019)

An Updated Version of the Treatment Effectiveness Assessment (TEA) [Letter]
por: Ling, Walter, et al.
Publicado: (2020)

Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study
por: Dhanda, Rahul, et al.
Publicado: (2019)

Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder
por: Ronquest, Naoko A, et al.
Publicado: (2018)

Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings
por: Boyett, Brent, et al.
Publicado: (2023)

Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis
por: Andorn, Anne C., et al.
Publicado: (2020)

Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system
por: Boscarino, Joseph A, et al.
Publicado: (2016)

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
por: Solem, Caitlyn T, et al.
Publicado: (2016)

The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction
por: Ling, Walter, et al.
Publicado: (2012)

Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium avium Complex (MAC)
por: Shah, Anuj, et al.
Publicado: (2021)

Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians
por: Di Paola, Angela, et al.
Publicado: (2023)

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
por: Laffont, Celine M., et al.
Publicado: (2022)

The Metacognitions Questionnaire and Its Derivatives in Children and Adolescents: A Systematic Review of Psychometric Properties
por: Myers, Samuel G., et al.
Publicado: (2019)

Psychometric Properties of an Assessment for Mental Health Recovery Programs
por: Fisher, Dennis G., et al.
Publicado: (2009)

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder
por: Heidbreder, Christian, et al.
Publicado: (2023)

The Treatment Effectiveness Assessment (TEA)
por: Ling, Walter, et al.
Publicado: (2013)

A Tool for Forecasting the Arrival Time of a Tracer or a Pollutant at a Karst Spring
por: Preisig, Giona, et al.
Publicado: (2022)

Psychometric Properties of a Fidelity Scale for Illness Management and Recovery
por: Egeland, Karina Myhren, et al.
Publicado: (2019)

Psychometric properties of the Persian version of the quality of recovery-15 questionnaire
por: Shahsavari, Hooman, et al.
Publicado: (2021)

Psychometric Evaluation of the Postoperative Recovery Profile
por: Jakobsson, Jenny
Publicado: (2023)

CORE-OM as a routine outcome measure for adolescents with emotional disorders: factor structure and psychometric properties
por: Lorentzen, Veronica, et al.
Publicado: (2020)

Real‐world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States
por: Pizzicato, Lia N., et al.
Publicado: (2022)

The psychometric properties and clinical utility of neural measures of reward processing
por: Amir, Nader, et al.
Publicado: (2023)

Psychometric properties and clinical utility of the Scale for Suicidal Ideation (SSI) in adolescents
por: Holi, Matti M, et al.
Publicado: (2005)

Recovery from eating disorders: psychometric properties of a patient-related measure
por: Pettersen, Gunn, et al.
Publicado: (2012)

Development and Psychometric Properties of the Women’s Recovery of Postnatal Perineal Injuries Questionnaire (WRPPIQ)
por: Jahani Shoorab, Nahid, et al.
Publicado: (2020)

Measuring Recovery Related Outcomes: A Psychometric Investigation of the Recovery Markers Inventory
por: Lusczakoski, Kate DeRoche, et al.
Publicado: (2014)

“The Italian Study on Recovery 2” Phase 1: Psychometric Properties of the Recovery Assessment Scale (RAS), Italian Validation of the Recovery Assessment Scale
por: Boggian, Ileana, et al.
Publicado: (2020)

In response to: anesthesia for minimally invasive cardiac surgery: is it still a place for opioids?
por: Patvardhan, Chinmay, et al.
Publicado: (2021)

Social determinants of health in pulmonary arterial hypertension patients in the United States: Clinician perspective and health policy implications
por: Nadipelli, Vijay R., et al.
Publicado: (2022)

Effect of opioid dependence or abuse on opioid utilization after shoulder arthroplasty
por: Berglund, Derek D, et al.
Publicado: (2018)

The Psychometric Properties and Clinical Utility of the Korean Version of GAD-7 and GAD-2
por: Ahn, Jung-Kwang, et al.
Publicado: (2019)

The Spanish validation of the Short Health Anxiety Inventory: Psychometric properties and clinical utility
por: Arnáez, Sandra, et al.
Publicado: (2019)

Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis
por: AbuDagga, Azza, et al.
Publicado: (2013)

Perceptions of COVID-19 vaccine side effects by political affiliation
por: Farabee, David, et al.
Publicado: (2023)

A Simple, Personalized Opioid Stratification Pathway Dramatically Reduces Opioid Utilization
por: Deen, Justin T., et al.
Publicado: (2020)

Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis
por: Solem, Caitlyn T., et al.
Publicado: (2016)

Diagnostic Utility and Psychometric Properties of the Beck Depression Inventory-II Among Korean Adults
por: Park, Kiho, et al.
Publicado: (2020)

Psychometric properties and comparison of four health utility approaches among myopia patients in China
por: Dou, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_68cgkn6uioj8b49oqmm7pdiboo